GO:1901256 regulation of macrophage colony-stimulating factor production: Cytokine Regulation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901256 describes any process that modulates the frequency, rate or extent of macrophage colony-stimulating factor (M-CSF/CSF1) production.
• M-CSF (CSF1) is a key cytokine that controls macrophage differentiation, proliferation, and survival in development, homeostasis, and tissue repair.
• Regulation of M-CSF production is critical in hematopoiesis, immune responses, and diseases such as atherosclerosis and cancer.
• Sleep and circadian rhythms modulate haematopoiesis and M-CSF production, linking lifestyle factors to cardiovascular risk.
• Tumor-associated macrophages and monocytes show cancer-specific reprogramming that involves M-CSF signaling, making it a therapeutic target.
• Experimental models for studying M-CSF regulation include bone marrow-derived macrophage differentiation, knockout mice, and CRISPR-based editing.
Description
Macrophage colony-stimulating factor (M-CSF), also known as colony-stimulating factor 1 (CSF1), is a cytokine that regulates the survival, proliferation, and differentiation of mononuclear phagocytes, including macrophages and monocytes. The production of M-CSF is tightly controlled because it influences haematopoiesis, immune surveillance, and tissue remodeling. The Gene Ontology term GO:1901256, regulation of macrophage colony-stimulating factor production, captures any process that modulates the frequency, rate or extent of M-CSF production. Understanding this regulation is essential for researchers studying inflammation, cancer, atherosclerosis, and reproductive biology. M-CSF is produced by various cell types, including stromal cells, osteoblasts, and granulosa cells, and its expression is induced by inflammatory stimuli and hormonal signals. Dysregulation of M-CSF production contributes to pathological conditions such as tumor progression and chronic inflammatory diseases. Therefore, investigating the molecular mechanisms that control M-CSF production can reveal new therapeutic targets and biomarkers.
regulation of macrophage colony-stimulating factor production At A Glance
| GO ID | GO:1901256 |
|---|---|
| GO term | regulation of macrophage colony-stimulating factor production |
| Ontology | biological_process |
| Synonym | regulation of M-CSF production |
| Major function | Modulates the frequency, rate or extent of M-CSF (CSF1) production, influencing macrophage differentiation, proliferation, and survival. |
| Related cytokine | Macrophage colony-stimulating factor (M-CSF/CSF1) |
| Key cell types | Monocytes, macrophages, granulosa cells, testicular macrophages, stromal cells |
| Associated diseases | Atherosclerosis, cancer, inflammatory disorders |
| Research methods | Bone marrow macrophage differentiation, knockout models, CRISPR editing, transcriptomics |
What Is GO:1901256?
GO:1901256 is defined as any process that modulates the frequency, rate or extent of macrophage colony-stimulating factor production. In other words, it encompasses all biological mechanisms that control how much M-CSF (CSF1) is synthesized and secreted by cells, including transcriptional, post-transcriptional, and signaling events that alter M-CSF levels.
Why Is regulation of macrophage colony-stimulating factor production Important in Cell Biology?
Regulation of M-CSF production is important because M-CSF is a central regulator of macrophage biology, and its dysregulation is linked to major human diseases including atherosclerosis, cancer, and chronic inflammation. Understanding how M-CSF production is controlled can lead to new strategies for modulating immune responses and treating diseases where macrophages play a pathogenic role.
• Controls macrophage differentiation and survival, impacting innate immunity.
• Influences haematopoiesis and hematopoietic stem cell mobilization.
• Plays a role in atherosclerosis development and plaque progression.
• Modulates tumor-associated macrophage reprogramming in cancer.
• Regulates reproductive processes such as ovarian function and testicular immunity.
• Involved in tissue repair and homeostasis.
• Provides a target for anti-cancer therapies aimed at tumor-associated macrophages.
• Links sleep and circadian rhythms to cardiovascular health.
• Serves as a biomarker for monocyte/macrophage activation.
• Enables experimental modeling of macrophage-related diseases.
What Happens During regulation of macrophage colony-stimulating factor production?
Transcriptional control of M-CSF (CSF1) gene expression
In simple terms: The cell decides how much M-CSF mRNA to make from the CSF1 gene.
M-CSF production is primarily regulated at the transcriptional level. Various transcription factors and signaling pathways, such as those activated by inflammatory cytokines, can bind to the CSF1 promoter and enhance or repress its transcription. For example, interferon regulatory factor 7 (IRF7) has been implicated in modulating the immune profile of testicular macrophages, potentially affecting M-CSF production.
Post-transcriptional and post-translational regulation
In simple terms: After mRNA is made, the cell can still control how much protein is produced and released.
M-CSF expression can also be regulated post-transcriptionally, including mRNA stability and translation efficiency. Additionally, M-CSF is synthesized as a membrane-bound precursor that can be proteolytically cleaved to release soluble M-CSF, adding another layer of regulation. Urokinase-type plasminogen activator gene transcription can be regulated by M-CSF itself, indicating feedback loops.
Signaling pathways that modulate M-CSF production
In simple terms: External signals tell the cell to make more or less M-CSF.
Various extracellular stimuli, such as growth factors, hormones, and cytokines, can activate intracellular signaling cascades that converge on the nucleus to regulate CSF1 transcription. For instance, in human granulosa cells, M-CSF production is influenced by hormonal signals. In testicular macrophages, M-CSF and IRF7 interact to modulate the immune environment.
Feedback and autocrine regulation
In simple terms: M-CSF can influence its own production through feedback loops.
M-CSF can act in an autocrine manner on macrophages, and its signaling may feed back to regulate its own expression. For example, M-CSF regulates the transcription of the urokinase-type plasminogen activator gene, which may in turn affect macrophage function and M-CSF production. Such feedback mechanisms help maintain homeostasis but can become dysregulated in disease.
Integration with systemic factors
In simple terms: Whole-body signals like sleep and stress can change M-CSF levels.
Systemic factors such as sleep and circadian rhythms can modulate haematopoiesis and M-CSF production. Sleep fragmentation has been shown to increase monocyte production and atherosclerosis in mice, partly through effects on M-CSF. This highlights how physiological states can regulate M-CSF production.
Key Genes Involved in GO:1901256 regulation of macrophage colony-stimulating factor production
The following genes and proteins are key players in the regulation of macrophage colony-stimulating factor production, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CSF1 | Encodes macrophage colony-stimulating factor (M-CSF); its production is the target of regulation | Central to studies of macrophage differentiation and function |
| CSF1R | Receptor for M-CSF; mediates signaling that can feedback to regulate M-CSF production | Target for modulating macrophage responses |
| IRF7 | Interferon regulatory factor 7; modulates immune profile of testicular macrophages and may influence M-CSF production | Studied in reproductive immunology |
| PLAU | Urokinase-type plasminogen activator; its transcription is regulated by M-CSF | Links M-CSF to extracellular matrix remodeling |
| IL34 | Interleukin 34; another ligand for CSF1R, may cross-regulate M-CSF production | Alternative macrophage growth factor |
| NFKB1 | NF-kB subunit; mediates inflammatory signaling that can induce M-CSF transcription | Inflammation-related M-CSF regulation |
| STAT3 | Signal transducer and activator of transcription 3; involved in cytokine signaling | Potential regulator of M-CSF expression |
| CEBPB | CCAAT/enhancer-binding protein beta; transcription factor that can regulate CSF1 promoter | Myeloid differentiation-related |
| SPI1 | PU.1; master regulator of myeloid gene expression, may control CSF1 transcription | Macrophage development |
| JUN | AP-1 transcription factor component; responds to inflammatory signals | Stress and inflammation pathways |
| FOS | AP-1 transcription factor component; partners with JUN | Inflammatory gene regulation |
| RELA | NF-kB p65 subunit; activates many inflammatory genes | Innate immunity |
| MAPK1 | ERK2; kinase in MAPK pathway that can regulate transcription factors | Signal transduction |
| MAPK3 | ERK1; kinase in MAPK pathway | Signal transduction |
| PIK3CA | PI3K catalytic subunit; involved in signaling to M-CSF production | Growth factor signaling |
| AKT1 | AKT serine/threonine kinase 1; downstream of PI3K | Cell survival and metabolism |
| MTOR | Mechanistic target of rapamycin; integrates nutrient and growth signals | Translational regulation |
| HIF1A | Hypoxia-inducible factor 1 alpha; can induce M-CSF under hypoxia | Tumor microenvironment |
How Is regulation of macrophage colony-stimulating factor production Regulated?
The regulation of M-CSF production is itself controlled by a network of signaling pathways and transcription factors. Inflammatory stimuli such as lipopolysaccharide (LPS) and cytokines like TNF-alpha can activate NF-kB and AP-1, which bind to the CSF1 promoter and enhance transcription. Growth factor signaling through PI3K/AKT and MAPK pathways can also modulate M-CSF expression. Additionally, hypoxia-inducible factor 1 alpha (HIF1A) can upregulate M-CSF under low oxygen conditions, as seen in tumors. Post-transcriptional mechanisms, including microRNAs and RNA-binding proteins, add further complexity. Systemic factors like sleep and circadian rhythms influence haematopoiesis and M-CSF levels, as shown in mouse models. Feedback loops involving M-CSF signaling through CSF1R can also affect its own production.
regulation of macrophage colony-stimulating factor production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CSF1 | Atherosclerosis; M-CSF promotes plaque macrophages | ApoE-/- mice with sleep fragmentation |
| CSF1 | Cancer; TAM recruitment and polarization | Tumor-bearing mice with CSF1 knockout |
| CSF1 | Ovarian dysfunction; M-CSF in granulosa cells | Human granulosa cell culture |
| CSF1 | Testicular immune privilege; M-CSF and IRF7 interaction | Irf7-/- mice |
| CSF1R | Inflammatory diseases; M-CSF signaling | Csf1r knockout mice |
Atherosclerosis and cardiovascular disease
Sleep fragmentation increases monocyte production and accelerates atherosclerosis in mice, and this effect is associated with increased M-CSF levels. M-CSF promotes macrophage accumulation in arterial walls, contributing to plaque formation. Therefore, regulation of M-CSF production is a potential target for cardiovascular therapies.
Cancer and tumor-associated macrophages
Tumor-associated macrophages (TAMs) are abundant in many cancers and often display an M2-like pro-tumor phenotype. M-CSF is a key driver of TAM recruitment and polarization. Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming that involves M-CSF signaling, making it a therapeutic target. Regulating M-CSF production could alter the tumor microenvironment and improve immunotherapy outcomes.
Reproductive disorders
M-CSF is produced by human granulosa cells and plays a role in ovarian function. In the testis, M-CSF and IRF7 modulate the immune profile of testicular macrophages, which are important for spermatogenesis and immune privilege. Dysregulation of M-CSF production may contribute to reproductive disorders such as infertility.
Inflammatory and autoimmune diseases
M-CSF is elevated in various inflammatory conditions, including rheumatoid arthritis and inflammatory bowel disease, where it promotes macrophage activation and tissue damage. Regulating M-CSF production could reduce inflammation and tissue destruction.
From regulation of macrophage colony-stimulating factor production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate M-CSF production? | CRISPR knockout of gene X in macrophages |
| Does point mutation in CSF1 affect M-CSF secretion? | Knock-in mice with point mutation |
| Can we tag M-CSF for live imaging? | Knock-in of fluorescent tag into CSF1 locus |
| What is the effect of M-CSF overexpression? | Transgenic overexpression of CSF1 |
| Which genes regulate M-CSF in tumor microenvironment? | CRISPR library screening in cancer cells |
| How does sleep affect M-CSF production? | Sleep fragmentation mouse model |
How to Study the regulation of macrophage colony-stimulating factor production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Bone marrow macrophage differentiation | M-CSF-dependent macrophage growth | Studying M-CSF production and function |
| RNA-seq | Transcriptional changes | Identifying regulators of CSF1 expression |
| CRISPR knockout screening | Gene function on M-CSF production | Discovery of novel regulators |
| ELISA | M-CSF protein concentration | Quantifying secretion |
| Western blot | M-CSF protein levels | Validation of expression changes |
| Flow cytometry | Macrophage surface markers | Assessing differentiation |
| Immunohistochemistry | M-CSF in tissues | Localizing M-CSF in disease |
| Sleep fragmentation model | Systemic effects on M-CSF | Linking sleep to atherosclerosis |
Bone marrow-derived macrophage differentiation
Isolation of bone marrow cells and differentiation into macrophages using M-CSF is a standard method to study M-CSF production and function. This model allows researchers to assess how genetic perturbations affect M-CSF secretion and macrophage development.
Transcriptomic profiling
RNA-seq and single-cell RNA-seq can reveal transcriptional changes in genes involved in M-CSF production. Human tumor-associated macrophage landscapes have been characterized using transcriptomics, identifying cancer-specific reprogramming.
CRISPR-based genetic screens
CRISPR knockout libraries can be used to identify genes that regulate M-CSF production. Such screens have been applied to discover therapeutic targets in cancer.
Protein detection and quantification
ELISA, Western blot, and proteomics can measure M-CSF protein levels in cell culture supernatants and tissues. These methods are essential to validate findings from genetic studies.
How CRISPR Can Be Used to Study GO:1901256 regulation of macrophage colony-stimulating factor production
Knockout
CRISPR knockout of candidate genes in macrophages or other M-CSF-producing cells can determine whether they are required for M-CSF production. For example, knocking out IRF7 in testicular macrophages could reveal its role in M-CSF regulation. Knockout models are also used to study M-CSF function in vivo.
Point Mutation
Introducing point mutations in the CSF1 gene or its regulatory regions can help dissect specific signaling motifs or transcription factor binding sites. This approach can reveal how single amino acid changes affect M-CSF secretion or activity.
Knock-in
Knock-in of reporter genes (e.g., GFP) into the CSF1 locus allows real-time monitoring of M-CSF expression in live cells and tissues. This is valuable for tracking M-CSF-producing cells in development and disease.
Overexpression
Overexpression of CSF1 or upstream regulators can model conditions of excess M-CSF, such as in tumors or inflammatory diseases. This helps establish causality between M-CSF levels and disease phenotypes.
How EDITGENE Supports regulation of macrophage colony-stimulating factor production Research
Researchers studying regulation of macrophage colony-stimulating factor production-related genes often need to determine whether a candidate gene is causally involved in M-CSF regulation or is merely correlated. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of macrophage colony-stimulating factor production research.
Frequently Asked Questions About regulation of macrophage colony-stimulating factor production
What is GO:1901256?
GO:1901256 is a Gene Ontology term for regulation of macrophage colony-stimulating factor production, describing any process that modulates the frequency, rate or extent of M-CSF production.
What is macrophage colony-stimulating factor?
Macrophage colony-stimulating factor (M-CSF), also known as CSF1, is a cytokine that regulates the survival, proliferation, and differentiation of macrophages and monocytes.
What genes are involved in regulation of M-CSF production?
Key genes include CSF1, CSF1R, IRF7, PLAU, and various transcription factors like NF-kB and AP-1 components.
How is M-CSF production regulated?
M-CSF production is regulated at transcriptional, post-transcriptional, and post-translational levels by inflammatory signals, hormones, and systemic factors like sleep.
Why is M-CSF important in cancer?
M-CSF drives recruitment and polarization of tumor-associated macrophages, which can promote tumor progression and suppress anti-tumor immunity.
What diseases are associated with M-CSF dysregulation?
Atherosclerosis, cancer, inflammatory diseases, and reproductive disorders have been linked to altered M-CSF production.
How can I study M-CSF production in the lab?
Common methods include bone marrow-derived macrophage differentiation, ELISA, RNA-seq, and CRISPR knockout models.
What is the role of sleep in M-CSF production?
Sleep fragmentation increases monocyte production and atherosclerosis in mice, associated with increased M-CSF levels.
Can CRISPR be used to study M-CSF regulation?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect the genetic regulation of M-CSF production.
What services does EDITGENE offer for M-CSF research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to M-CSF research.
Conclusion
Regulation of macrophage colony-stimulating factor production (GO:1901256) is a critical biological process that controls macrophage development and function. Its dysregulation is implicated in atherosclerosis, cancer, and inflammatory diseases. Understanding the molecular mechanisms and key genes involved can lead to new therapeutic strategies. EDITGENE offers comprehensive CRISPR services to facilitate functional studies of M-CSF regulation.
References
- 1. McAlpine CS et al.. 2019. Sleep modulates haematopoiesis and protects against atherosclerosis.. Nature 566(7744):383-387 PMID: 30760925
- 2. Cassetta L et al.. 2019. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.. Cancer Cell 35(4):588-602.e10 PMID: 30930117
- 3. Mendoza R et al.. 2022. Mouse Bone Marrow Cell Isolation and Macrophage Differentiation.. Methods Mol Biol 2455:85-91 PMID: 35212988
- 4. Sehgal A et al.. 2021. Functions of macrophage colony-stimulating factor (CSF1) in development, homeostasis, and tissue repair.. Semin Immunol 54:101509 PMID: 34742624
- 5. Stanley ER et al.. 1997. Biology and action of colony--stimulating factor-1.. Mol Reprod Dev 46(1):4-10 PMID: 8981357
- 6. Xu S et al.. 2016. Role of macrophage colony-stimulating factor (M-CSF) in human granulosa cells.. Gynecol Endocrinol 32(12):1005-1008 PMID: 27791429
- 7. Yang Y et al.. 2024. Role of macrophage colony stimulating factor and interferon regulatory factor 7 in modulating the immune profile of mouse testicular macrophages.. J Reprod Immunol 161:104169 PMID: 38016190
- 8. Stacey KJ et al.. 1995. Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor.. Mol Cell Biol 15(6):3430-41 PMID: 7760840
